Clinical Outcomes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems

Table 3

Multivariate analysis.

	Mortality		Unadjusted OR	Adjusted OR
	No (n = 99)	Yes (n = 15)
Vascular catheter LSI	1 (1.0)	0 (0.0)	—	—	—
CLSI	0 (0.0)	0 (0.0)	—	—	—
Ventilator-related infection	0 (0.0)	0 (0.0)	—	—	—
Bacteremia	8 (8.1)	1 (6.7)	0.81 (0.02–6.92)	0.63 (0.07–6.08)	0.692
Sepsis shock	14 (14.1)	1 (6.7)	0.43 (0.01–3.34)	0.31 (0.03–3.00)	0.314
Intra-abdominal infection	7 (7.1)	0 (0.0)	0.00 (0.00–3.57)	—	—
Pneumonia	6 (6.1)	3 (20.0)	3.87 (0.54–20.9)	2.28 (0.26–20.15)	0.458
Skin and soft tissue infection	17 (17.2)	1 (6.7)	0.34 (0.01–2.59)	0.26 (0.02–2.97)	0.278
Urinary tract infection	66 (66.7)	9 (60.0)	0.75 (0.21–2.79)	0.53 (0.10–2.84)	0.461